We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
-16.26%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
10 Year Est. Return
AUM
$11.8B
AUM Growth
-$2.13B
Cap. Flow
+$457M
Cap. Flow %
3.87%
Top 10 Hldgs %
9.66%
Holding
494
New
75
Increased
149
Reduced
153
Closed
37

Sector Composition

Rank Sector Weight
1 Healthcare 20.05%
2 Technology 17.64%
3 Industrials 14.71%
4 Consumer Discretionary 13.8%
5 Financials 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
226
Merck
MRK
$321B
$18.8M 0.16%
257,943
+18,971
+8% +$1.34M
UNP icon
227
Union Pacific
UNP
$172B
$18.5M 0.16%
133,581
+9,824
+8% +$1.46M
KEY icon
228
KeyCorp
KEY
$24.2B
$18.3M 0.16%
1,239,600
+641,900
+107% +$11.3M
LMT icon
229
Lockheed Martin
LMT
$132B
$18.1M 0.15%
69,046
+5,078
+8% +$1.54M
FOLD
230
DELISTED
Amicus Therapeutics
FOLD
$17.8M 0.15%
1,859,320
ORLY icon
231
O'Reilly Automotive
ORLY
$72.4B
$17.8M 0.15%
775,125
-81,750
-10% -$1.86M
ABT icon
232
Abbott
ABT
$183B
$17.5M 0.15%
242,245
+17,816
+8% +$1.25M
BBY icon
233
Best Buy
BBY
$18.5B
$17.2M 0.15%
325,325
+118,125
+57% +$7.72M
ADI icon
234
Analog Devices
ADI
$179B
$17M 0.14%
197,500
+159,075
+414% +$13.8M
MDT icon
235
Medtronic
MDT
$110B
$16.8M 0.14%
184,189
+13,546
+8% +$1.27M
PGNX
236
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$16.6M 0.14%
3,948,024
XYL icon
237
Xylem
XYL
$27.3B
$16.6M 0.14%
248,475
+27,825
+13% +$1.93M
FHN icon
238
First Horizon
FHN
$12.1B
$16.5M 0.14%
1,256,725
-562,425
-31% -$8.75M
CCL icon
239
Carnival Corporation Ltd
CCL
$38B
$16.5M 0.14%
334,809
+24,624
+8% +$1.41M
CBAY
240
DELISTED
Cymabay Therapeutics
CBAY
$16.2M 0.14%
2,061,772
WFC icon
241
Wells Fargo
WFC
$258B
$16.2M 0.14%
351,357
+25,841
+8% +$1.32M
TSCO icon
242
Tractor Supply
TSCO
$15.8B
$16.1M 0.14%
966,625
+46,500
+5% +$834K
CCI icon
243
Crown Castle
CCI
$33.4B
$15.9M 0.13%
146,691
+10,788
+8% +$1.19M
BWXT icon
244
BWX Technologies
BWXT
$15.2B
$15.9M 0.13%
416,450
+83,425
+25% +$4.14M
AVGO icon
245
Broadcom
AVGO
$1.85T
$15.9M 0.13%
+40,430
New +$954K
TTE icon
246
TotalEnergies
TTE
$193B
$15.9M 0.13%
304,357
+22,384
+8% +$1.28M
PEP icon
247
PepsiCo
PEP
$191B
$15.2M 0.13%
137,652
+10,124
+8% +$1.14M
MO icon
248
Altria Group
MO
$113B
$15.1M 0.13%
305,992
+87,189
+40% +$5.05M
DVAX
249
DELISTED
Dynavax Technologies
DVAX
$15M 0.13%
1,636,176
HST icon
250
Host Hotels & Resorts
HST
$17.2B
$14.9M 0.13%
892,984
-1,320,650
-60% -$24.7M

Similar funds

Carillon Tower Advisers's Q4 2018 Portfolio in Review

As of Q4 2018, Carillon Tower Advisers held 494 positions worth $11.8B, down 15% from $13.9B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.

Carillon Tower Advisers deployed $457M of net new capital in Q4 2018, opening 75 new positions and adding to 149 existing holdings. Its largest new stake was AGNC Investment: 4,047,600 shares worth $71M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Abiomed Inc, an estimated $46M trimmed.

  • Carillon Tower Advisers's largest Q4 2018 buy was AGNC Investment: 4,047,600 shares worth $71M.
  • Carillon Tower Advisers added most to Centene in Q4 2018, an estimated $102M increase.
  • Carillon Tower Advisers's biggest Q4 2018 reduction was Abiomed Inc, cutting an estimated $46M.
  • Carillon Tower Advisers fully exited NutriSystem, Inc. in Q4 2018, selling an estimated $72.5M.
  • Carillon Tower Advisers's ten largest holdings make up 9.7% of its $11.8B portfolio in Q4 2018.
  • Carillon Tower Advisers opened 75 new positions and closed 37 in Q4 2018.
  • Carillon Tower Advisers's portfolio value fell 15% quarter-over-quarter to $11.8B.

Based on Carillon Tower Advisers's 13F filing for Q4 2018, filed 13 Feb 2019.